Company profile
Accelera Innovations, Inc
OTC: ACNV · Healthcare · Medical - Healthcare Information Services
#1148 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
——FH —DQ 18GM —SS 25
v0.1 · 25/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ return on assets, Altman-Z
Methodology →Revenue TTM
$1.3k
Rev growth YoY (TTM)
-97.0%
Net income (FY)
-$1.9M
Employees
3
as of 2026-08-30
Market cap
$8.1k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.8k$2.8k2016
Net income-$1.9M-$1.9M2016
Operating income-$1.9M-$1.9M2016
Total assets$9.6k$9.6k2016
Liabilities$2.4M$2.4M2016
Equity-$2.4M-$2.4M2016
Revenue trend
FY2013 – FY2016 · USD
FY13
FY14
FY15
FY16
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Accelera Innovations, Inc’s revenue?
Accelera Innovations, Inc booked $2.8k in FY2016 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -70010.7% net margin.
Peers · Healthcare
Caring Brands, Inc.22DBiora Therapeutics, Inc.——Aditxt, Inc.17DInstadose Pharma Corp.——Aibotics Inc.14DAtossa Therapeutics, Inc.30DNeighbors
El Paso →Key facts
CEOGeoffrey J. Thompson
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersColorado Springs, CO
ExchangeOTC: ACNV
Employees3
IPO date2015-01-27
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.